Robeco Institutional Asset Management B.V. Has $6.93 Million Stake in Danaher Corporation (DHR)
Robeco Institutional Asset Management B.V. increased its position in Danaher Corporation (NYSE:DHR) by 33.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,127 shares of the conglomerate’s stock after buying an additional 20,490 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Danaher Corporation were worth $6,931,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of DHR. Honeywell International Inc. acquired a new stake in Danaher Corporation during the second quarter worth approximately $25,317,000. Israel Discount Bank of New York purchased a new stake in Danaher Corporation in the 1st quarter worth approximately $209,000. Eastern Bank grew its stake in Danaher Corporation by 4,291.1% in the 2nd quarter. Eastern Bank now owns 128,001 shares of the conglomerate’s stock worth $10,802,000 after acquiring an additional 125,086 shares during the period. DE Burlo Group Inc. grew its stake in Danaher Corporation by 17.8% in the 1st quarter. DE Burlo Group Inc. now owns 131,450 shares of the conglomerate’s stock worth $11,242,000 after acquiring an additional 19,900 shares during the period. Finally, Perkins Coie Trust Co grew its stake in Danaher Corporation by 2.0% in the 2nd quarter. Perkins Coie Trust Co now owns 29,431 shares of the conglomerate’s stock worth $2,484,000 after acquiring an additional 586 shares during the period. 75.68% of the stock is owned by institutional investors and hedge funds.
In related news, insider William King sold 7,458 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Linda P. Hefner sold 10,578 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the sale, the director now directly owns 42,151 shares of the company’s stock, valued at approximately $3,499,797.53. The disclosure for this sale can be found here. Insiders have sold a total of 71,496 shares of company stock valued at $5,916,223 over the last ninety days. Company insiders own 12.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/robeco-institutional-asset-management-b-v-has-6-93-million-stake-in-danaher-corporation-dhr/1602272.html.
Shares of Danaher Corporation (NYSE DHR) opened at 85.78 on Monday. The firm’s 50-day moving average is $82.99 and its 200 day moving average is $84.20. The stock has a market capitalization of $59.59 billion, a P/E ratio of 27.38 and a beta of 1.03. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.62.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter last year, the firm earned $0.90 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts expect that Danaher Corporation will post $3.95 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.83%.
Several research analysts have weighed in on DHR shares. Janney Montgomery Scott downgraded Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a report on Thursday, June 15th. Zacks Investment Research cut Danaher Corporation from a “hold” rating to a “sell” rating in a report on Monday, June 19th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $97.00 price objective on shares of Danaher Corporation in a research report on Wednesday, June 21st. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $88.00 price objective on shares of Danaher Corporation in a research report on Wednesday, July 12th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $91.98.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.